Richard Sloma

Richard Sloma has extensive work experience in various roles within the pharmaceutical industry. Richard is currently serving as the Head of CQA at NeoImmuneTech, a position they have held since January 2023. Prior to this, they worked as a Senior Consultant at J&M Quality Operations from November 2021 to December 2022. From September 2018 to September 2021, Richard was the Head of Rare Disease CQA and Compliance at Takeda. Richard spent a significant portion of their career at Sanofi, starting in November 2009 and leaving in September 2018. During this time, they held multiple roles, including Clinical Contracts and GCP Quality Auditor. Before joining Sanofi, they worked as an Engineering & Global Procurement professional at Merck from 1997 to 2009. Overall, Richard Sloma has over 20 years of experience in the industry, with a focus on CQA, compliance, and procurement.

Richard Sloma completed their education in a chronological order. Richard first attended the New Jersey Institute of Technology from 1995 to 1998, where they pursued a degree in Chemical Engineering. Following that, they enrolled at Rutgers University from 2004 to 2005, where they obtained a Master of Business Administration (MBA) with a focus on Economics.